Change of 12.76% for TAKEDA PHARMACEUTICAL CO LTD ORDINARY SH (OTCMKTS:TKPHF)’s shares shorted was noted. In November was announced TKPHF’s total 19.22 million shares shorted by FINRA. That’s 12.76% up from 17.05M shares. TAKEDA PHARMACEUTICAL CO LTD ORDINARY SH (OTCMKTS:TKPHF) has 14,700 shares average volume. It’ll cost 1308 days for TKPHF to recover its previous position.
The stock decreased 4.31% or $1.76 during the last trading session, reaching $39.1.Currently Takeda Pharmaceutical Company Limited is after 0.00% change in last November 10, 2017. TKPHF has also 24,786 shares volume. TKPHF underperformed the S&P 500 by 15.62%.
Takeda Pharmaceutical Company Limited engages in the research and development, manufacture, marketing, and sale of pharmaceutical products worldwide.The company has $31.25 billion market cap. The firm operates in three divisions: Prescription Drug, Consumer Healthcare, and Other.28.15 is the P/E ratio. It offers prescription, OTC, and quasi-drugs; and reagents in various therapeutic areas, including oncology, gastroenterology, central nervous system, vaccines, and others.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.